Proactive Investors - Run By Investors For Investors

LexaGene moves forward with its faster, easier pathogen detection

LexaGene Holdings (CVE:LXG) (OTCQB:LXXGF) Co-founder and CEO Dr. Jack Regan joined Katie Lewis from the Vancouver studio of Proactive Investors to discuss the firm's recent announcement.

LexaGene's key feature is the open access nature of the instrument that allows end users to customize the instrument to target any pathogen of interest. The process is as simple as collecting a sample, loading it into the instrument using a preparation cartridge and pressing “go.” The instrument is able to process multiple samples at a time, returning results within around one hour.forward with its faster, easier pathogen detection

 
Meet Yellow Cake PLC, Avation PLC, Manolete Partners PLC and Crossword Cybersecurity Plc at our event, London , 05 September 2019. Register here »
View full LXG profile View Profile

Lexagene Holdings Inc Timeline

© Proactive Investors 2019

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use